Correlation Between Tela Bio and Phathom Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Tela Bio and Phathom Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tela Bio and Phathom Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tela Bio and Phathom Pharmaceuticals, you can compare the effects of market volatilities on Tela Bio and Phathom Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tela Bio with a short position of Phathom Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tela Bio and Phathom Pharmaceuticals.
Diversification Opportunities for Tela Bio and Phathom Pharmaceuticals
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tela and Phathom is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Tela Bio and Phathom Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phathom Pharmaceuticals and Tela Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tela Bio are associated (or correlated) with Phathom Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phathom Pharmaceuticals has no effect on the direction of Tela Bio i.e., Tela Bio and Phathom Pharmaceuticals go up and down completely randomly.
Pair Corralation between Tela Bio and Phathom Pharmaceuticals
Given the investment horizon of 90 days Tela Bio is expected to under-perform the Phathom Pharmaceuticals. In addition to that, Tela Bio is 1.21 times more volatile than Phathom Pharmaceuticals. It trades about -0.06 of its total potential returns per unit of risk. Phathom Pharmaceuticals is currently generating about 0.13 per unit of volatility. If you would invest 891.00 in Phathom Pharmaceuticals on July 2, 2025 and sell it today you would earn a total of 286.00 from holding Phathom Pharmaceuticals or generate 32.1% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Tela Bio vs. Phathom Pharmaceuticals
Performance |
Timeline |
Tela Bio |
Phathom Pharmaceuticals |
Tela Bio and Phathom Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tela Bio and Phathom Pharmaceuticals
The main advantage of trading using opposite Tela Bio and Phathom Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tela Bio position performs unexpectedly, Phathom Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phathom Pharmaceuticals will offset losses from the drop in Phathom Pharmaceuticals' long position.Tela Bio vs. Avita Medical | Tela Bio vs. Clearpoint Neuro | Tela Bio vs. Sight Sciences | Tela Bio vs. Treace Medical Concepts |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements |